Compositions and methods for reducing cellular fat and for predicting cardiac toxicity and upon treatment with tyrosine kinase inhibitors

Details for Australian Patent Application No. 2007220094 (hide)

Owner TARGETED MOLECULAR DIAGNOSTICS, LLC

Inventors Bacus, Sarah S.

Agent Griffith Hack

Pub. Number AU-A-2007220094

PCT Pub. Number WO2007/101191

Priority 60/828,345 05.10.06 US; 60/777,096 27.02.06 US; 60/867,736 29.11.06 US; 60/827,372 28.09.06 US; 60/821,230 02.08.06 US

Filing date 27 February 2007

Wipo publication date 7 September 2007

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 13/22 (2006.01) Preparation of nitrogen-containing organic compounds

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/101191 Priority application(s): WO2007/101191

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007220102-Apparatus for delivering sealant at a predetermined pressure to a stuffing box of a shaft

2007220073-Auxiliary writes over address channel